7,376.86

+23.13

+0.31%

51,285.73

-237.33

-0.46%

24,579.42

+264.43

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,731.37

-73.03

-0.10%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

OTC Markets OTCPK - Delayed Quote USD

Aditxt, Inc. (ADTX)

0.0007 +0.0006 (+600.00%)

At close: November 6 at 4:00:00 PM EST

Loading Chart for ADTX

Chart Range Bar

Interval:

In partnership with ChartIQ

ADTX Stock Surges 40% Overnight: New 10% Holder Emerges After Aditxt’s Ignite Proteomics SPAC Deal

ADTX Stock Surges 40% Overnight: New 10% Holder Emerges After Aditxt’s Ignite Proteomics SPAC Deal

ADTX Stock Rockets 90% Premarket: What's Fueling Rebound After A Record 22-Day Selloff?

ADTX Stock Rockets 90% Premarket: What's Fueling Rebound After A Record 22-Day Selloff?

Why Is ADTX Stock In Spotlight Today?

Why Is ADTX Stock In Spotlight Today?

Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million

Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million

Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders

Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders

Aditxt and Ignite announce merger plans with strategic partner

Aditxt and Ignite announce merger plans with strategic partner

ADTX Stock Loses Nasdaq Listing After Seven Reverse Splits Fail To Restore Compliance: Why Is Retail Still Bullish?

ADTX Stock Loses Nasdaq Listing After Seven Reverse Splits Fail To Restore Compliance: Why Is Retail Still Bullish?

Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection

Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection

Wall Street Set to Open Higher Wednesday as Investors Dissect Mixed Jobs Report, Look Ahead to Thursday's Inflation Data

Wall Street Set to Open Higher Wednesday as Investors Dissect Mixed Jobs Report, Look Ahead to Thursday's Inflation Data

Mobilize your Website

View Site in Mobile | Classic

Share by: